- Home
- Personal Injury
- PFAS Lawsuit
- Is There a Connection Between PFAS and Preeclampsia?
Is There a Connection Between PFAS and Preeclampsia?
- Last updated: July 17, 2025
-
Contributor: nicky
PFAS, or perfluoroalkyl and polyfluoroalkyl substances, are man-made chemicals used in various industrial and consumer products for their resistance to heat, oil and water. They persist in the environment for decades, and many communities worldwide continue to discover them in soil, drinking water and food. As these substances gain more attention, we find ourselves confronting a critical question: what are the possible links between PFAS and preeclampsia, a serious complication of pregnancy?
We know that preeclampsia, characterized by high blood pressure and organ dysfunction, is a leading cause of maternal and fetal health complications. Researchers have been investigating whether long-term exposure to PFAS might influence the development or severity of this condition. Several observational and meta-analysis studies suggest that PFAS exposure may indeed play a role in preeclampsia risk, particularly when it involves chemicals such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS).
In this article, we focus on what the science currently says about PFAS, how expecting parents can safeguard themselves from unwelcome exposure, and what legal or medical options exist for families facing potential harm. We also examine ways to minimize PFAS in daily life, from water supply precautions to informed product choices.
What Is Preeclampsia and Why Is It Serious?
Preeclampsia is a pregnancy complication that typically appears after the 20th week of gestation. It is primarily marked by high blood pressure and can affect organs such as the liver and kidneys. Doctors often diagnose it through elevated blood pressure readings and protein in the urine, but additional blood tests, swelling in the limbs and severe headaches may also be indicators.
If left untreated, preeclampsia can lead to life-threatening complications, including eclampsia (seizures) or HELLP syndrome (a severe liver and blood cell disorder). In severe cases, healthcare providers may recommend delivering the baby prematurely to protect both mother and child. This balancing act between preventing harm to the mother versus allowing the fetus more time to mature underscores the gravity of preeclampsia.
Studies show that preeclampsia contributes significantly to worldwide maternal mortality rates. It can also affect long-term cardiovascular health in mothers and may influence the baby’s birth weight or long-term development. The involvement of potential external factors—like PFAS—makes this condition a subject of urgent medical research.
What Are PFAS and How Do They Enter the Body?
PFAS encompass thousands of chemical compounds. They have been strategically formulated for resistance to water, stains and heat, making them ideal for everything from firefighting foam to certain food packaging and kitchenware. Because they degrade very slowly, PFAS can accumulate in the environment and the human body.
Common routes of exposure include:
Consuming contaminated water. Areas near industrial sites or military bases can have higher PFAS concentrations in groundwater.
Eating contaminated food. PFAS can be found in certain products or packaging materials.
Using water- or stain-resistant consumer goods. Upholstery, carpeting and nonstick cookware can contain PFAS that migrate into air or dust.
PFAS can enter the bloodstream and remain for years. Pregnancy is a unique period where changes in metabolism and hormone levels may alter how these substances circulate. Researchers have examined PFAS concentrations in maternal blood to see if they correlate with health issues such as preeclampsia.
How Might PFAS Exposure Affect Pregnancy?
During pregnancy, the placenta plays a critical role in nutrition and waste exchange between mother and fetus. Some scientific evidence indicates that PFAS can cross the placenta, potentially affecting fetal development in multiple ways. Studies have noted connections between PFAS exposure and adverse pregnancy outcomes such as reduced birth weight, heightened risk of gestational hypertension and overall placental dysfunction.
In the context of preeclampsia, the body’s vascular function is particularly relevant. Preeclampsia is often linked to malfunctions in the blood vessels that supply the placenta, which might be exacerbated by factors that promote systemic inflammation or oxidative stress. Although the exact biological mechanisms remain under investigation, experts suggest PFAS may disrupt hormone pathways or receptors integral to healthy blood vessel function in the placenta. For example, PFAS can interact with peroxisome proliferator-activated receptors (PPARs), which are involved in lipid metabolism and other critical processes for placental health.
While animal studies have offered insights into how PFAS might trigger inflammation or hormone imbalances, human epidemiological evidence has grown in recent years. Some individuals who were exposed to PFAS through industrial accidents or contaminated water supplies have demonstrated a range of health issues, and researchers continue to scrutinize whether PFAS exposure heightens susceptibility to hypertension-related pregnancy complications.
What Does the Research Say About PFAS and Preeclampsia?
A systematic review and meta-analysis, integrating data from multiple studies, found a moderate association between PFAS exposure and preeclampsia risk. Notably, maternal perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) exposures appeared to be more consistently correlated with a rise in preeclampsia incidence. The research also indicated zero heterogeneity in combined PFAS exposure, meaning the overall effect across multiple studies showed consistent outcomes.
Key findings include:
Maternal PFOA exposure was linked to an increased risk of preeclampsia and other hypertensive disorders, with some analyses demonstrating statistical significance.
PFOS exposure also showed moderate associations, mirroring PFOA in its correlation to high blood pressure during pregnancy.
Other PFAS, such as perfluorohexane sulfonate (PFHxS), yielded conflicting or inconclusive findings, suggesting that not all PFAS carry the same degree of risk.
These studies typically controlled for factors like the mother’s age and pre-pregnancy weight but cited the need for further inquiry into how varying levels of PFAS, different PFAS types and the timing of exposure might each influence health outcomes. Additionally, conflicting results in certain studies underscore the complexity of isolating one factor—environmental or otherwise—in a condition like preeclampsia.
One nested case-control study in Guangxi, China especially highlighted the necessity for additional research into how PFAS might affect different preeclampsia subtypes. It also emphasized investigating biomarkers of preeclampsia risk, presumably looking for early warning signs that might be traced to environmental triggers such as PFAS.
We recognize that no one study is definitive, but the overall consensus suggests caution. Observational studies connect higher levels of PFAS in maternal blood with elevated odds of preeclampsia or other hypertensive disorders. Although more work is needed to pinpoint medical thresholds for concern, there is enough evidence to warrant preventive steps for expecting parents.
Are Certain Types of PFAS More Strongly Linked?
PFAS is a broad category encompassing outlets of older “long-chain” compounds like PFOA and PFOS, as well as newer “short-chain” or alternative PFAS (e.g., GenX). Historically, PFOA and PFOS were the focus of regulatory attention due to their persistence in the environment. Many manufacturers began phasing them out as early as the 2000s.
However, research indicates that the absence of PFOS and PFOA does not guarantee safety. Several newer PFAS variations share structural properties that raise similar concerns about bioaccumulation and potential toxicity. In the meta-analyses conducted to date, PFOA and PFOS do appear to lead the list of compounds most frequently associated with hypertensive issues like preeclampsia. PFHxS, by contrast, has shown a weaker or no notable relationship.
The consistent findings for PFOS and PFOA likely stem from the fact that they have been extensively studied. Their levels in human blood samples worldwide also tend to be higher than those of newer PFAS, which might not have had enough time to accumulate on the same scale. We continue to see new studies examining replacements for the older PFAS, but so far, they suggest the potential for similar health impacts, highlighting the need for ongoing surveillance.
When During Pregnancy Does PFAS Exposure Pose the Most Risk?
One question scientists continue to examine is the timing of exposure. Preeclampsia generally surfaces after 20 weeks of gestation, yet some researchers hypothesize that PFAS exposure before or early in pregnancy could set the stage for complications. During the first trimester, the placenta undergoes rapid development. Any disruptive agent—including PFAS—may generate a cascading effect through hormonal imbalances or inflammation that intensifies as the pregnancy progresses.
Specifically, maternal blood concentrations of PFAS can change throughout pregnancy and postpartum. Some studies measure PFAS levels at different trimesters to see whether higher PFAS concentrations at particular stages correlate with adverse outcomes. While a definitive timeline for PFAS-related risk is not firmly established, it is typically advised to avoid unnecessary exposures at every stage of pregnancy. Early screening for nutritional or environmental risk factors may help healthcare professionals tailor interventions and watch for preeclampsia symptoms more closely.
Are Pregnant Women Routinely Tested for PFAS?
Routine testing for PFAS is typically not part of standard prenatal care. Most healthcare providers focus on broader markers of pregnancy health, such as blood pressure, blood tests and fetal growth measures. PFAS testing can be expensive, and guidelines for safe or unsafe levels of PFAS remain under debate.
Despite the lack of routine testing, some areas with a history of industrial contamination or known environmental pollution have initiated localized screening programs. These efforts may involve testing water supplies, advising residents about potential PFAS hotspots or offering voluntary blood tests for pregnant women.
If you believe you have been exposed, you can consider consulting a pfas testing lab or a healthcare professional familiar with environmental health. Although the result might not directly change your prenatal care plan, knowing your PFAS levels can help you make more informed decisions about reducing exposures.
What Can Expecting Parents Do to Minimize PFAS Exposure?
While complete avoidance of all PFAS is challenging, there are effective steps families can take to reduce their exposure. These changes can help protect against PFAS-linked health concerns during pregnancy and beyond.
Check your water source
If you rely on a private well or suspect contamination, testing your water is a critical first step. You can connect with a pfas testing lab to analyze samples.
If results indicate elevated levels, consider installing a water filtration system. Options include activated carbon filters, reverse osmosis and specialized resins. Some technologies are discussed in more detail here: does reverse osmosis remove pfas.
Choose safer cookware
Nonstick pans often contain or leach PFAS when heated. Instead, consider stainless steel, cast iron or ceramic cookware to reduce potential chemical migration.
Verify product labels
Many food wrappers, stain-resistant sprays and fast-food packages may contain PFAS unless specifically labeled “PFAS-free.” Check the packaging or manufacturer’s website for details.
Advocate in your community
Local water treatment systems vary widely in their PFAS filtration methods. Advocate for pfas remediation efforts or stay updated on any regional pfas contamination map.
Consult medical professionals
If you are pregnant or planning a pregnancy, speak with your doctor about concerns over PFAS exposure. They might have region-specific guidance or extra prenatal monitoring to recommend.
By taking these steps, we can lower the likelihood of encountering dangerous PFAS concentrations that may complicate pregnancy. While these precautions are not an absolute guarantee against preeclampsia, they are proactive measures that can mitigate potential risks.
Can Preeclampsia and PFAS Exposure Lead to Long-Term Health Problems?
Preeclampsia itself can raise the risk of postpartum cardiovascular disease and metabolic issues for the mother in later years. Babies born from pregnancies complicated by preeclampsia may also have a higher likelihood of low birth weight or future metabolic disorders. According to multiple epidemiological studies, PFAS overlap with these risk factors by affecting cholesterol levels, thyroid function and immune response.
For example, the committee behind a series of PFAS-exposure evaluations has found evidence linking certain PFAS to dyslipidemia (abnormal cholesterol levels) and decreased birth weight. Because PFAS persist in the body, concerns remain about whether prolonged or repeated exposures might compound health risks over time.
Furthermore, PFAS and preeclampsia might each be tied to disturbances in placental function. The placenta, once compromised, can lead to fetal growth restriction and potential developmental challenges. Laboratory studies also point to possible interactions between PFAS and important hormone receptor pathways, suggesting that immunological and metabolic ramifications may endure beyond delivery.
We stress that preeclampsia can occur without any link to PFAS and that PFAS exposure does not guarantee complication. However, the overlapping physiological pathways demand closer scientific attention to clarify which proportion of risks might be attributable to PFAS in populations exposed to these chemicals.
Are There Legal or Medical Avenues for Families Affected?
Individuals and families who have experienced PFAS exposure, especially if it coincides with medical conditions like preeclampsia, sometimes explore legal options. In cases where industrial negligence or contamination has been proven, lawsuits may seek compensation for medical bills, ongoing care and other damages. If you believe your pregnancy complications could be tied to environmental exposures, legal counsel can help determine liability questions or initiate a claim.
We understand that “PFAS lawsuits” can be complex, often involving multiple parties and detailed scientific evidence. If you need guidance, you can visit the following page for a free case review and additional information at Legal Claim Assistant’s PFAS Lawsuit page
From a medical standpoint, families can maintain regular follow-up visits to monitor blood pressure, lipid profiles and organ function. Some specialists recommend postpartum cardiovascular screenings, especially for mothers who have had preeclampsia. We urge anyone suspecting exposure to PFAS to consider discussing enhanced screening with their obstetrician, primary care physician or environmental health expert.
Frequently Asked Questions (FAQ)
Is there’s a proven link between PFAS and preeclampsia?
Research shows a moderate association, especially with PFOA and PFOS, but not all studies agree entirely. The connection is supported by systematic reviews indicating zero heterogeneity for combined PFAS exposure. However, more research is needed to confirm how PFAS might directly contribute to or worsen preeclampsia.
How can I test for PFAS in my home water supply?
Homeowners can collect samples and send them to a certified pfas testing lab for analysis. Public water systems might also release annual water quality reports. If tests confirm contamination, it is possible to reduce levels with specialized filters or deeper pfas remediation initiatives.
Are there safe alternatives to nonstick cookware?
Yes. Stainless steel, ceramic or cast iron cookware does not typically use PFAS-based coatings and can be a safer option for those concerned about chemical leaching.
What if I have preeclampsia but no known PFAS exposure?
Preeclampsia has multiple causes, including genetics, preexisting hypertension and autoimmune issues. PFAS exposure is just one of many environmental factors under examination. We advise monitoring your condition with a healthcare provider to manage risks effectively.
Could preventing PFAS exposure lower my risk of getting preeclampsia?
It is difficult to give a definitive yes or no answer, because preeclampsia can occur from a combination of hormonal, immune and genetic factors. Reducing PFAS exposure, however, is a proactive measure and may lessen one potential source of stress on your system.
Do government agencies regulate PFAS?
In some countries, regulatory bodies have set advisories or limits for PFAS in drinking water. However, the standards vary widely, and there is ongoing debate about what threshold is truly safe. Individuals can stay informed through public health advisories and support stricter legislation.
Can I join a lawsuit if I live far from industrial sites?
PFAS contamination can spread through water systems, making distance from industrial sites less of a barrier. Each legal case is unique. If you suspect harm, it may be worth consulting an attorney to discuss your situation.
Could PFAS exposure affect other aspects of my health besides pregnancy?
Yes. Studies link PFAS exposure to disruptions in thyroid function, immunological responses and cardiovascular health. More research continues to uncover the full spectrum of health effects.
How can I raise awareness about PFAS risks in my community?
You can attend local government meetings, work with advocacy groups, or start petitions dealing with pfas contamination map data. Local news outlets may also be interested in highlighting community concerns.
Related Article